n. 208 (18): Dor On Line

Rvx 208

RVX 208 (RVX-208; RVX000222) is a first-in-class novel small molecule in development by Resverlogix Corporation for acute coronary syndromes, atherosclerosis and Alzheimer disease. It increases the levels of apolipoprotein A1 and high-density lipoprotein cholesterol, thereby potentially reducing the risk for cardiovascular disease. This review discusses the key development milestones and therap...

Gamma-ray multiplicities and fission modes in (208)Pb((18)O,f).

Two components in the M(gamma)(M) distribution were established in detailed measurements of mean gamma-ray multiplicities from fission fragments of (226)Th. For the first time in the M(gamma)(M) dependencies we were able to distinguish two components associated with primary and the final (after the neutron evaporation) fission fragments, and show that at the scission point M(gamma) is extremely...

Unlocking the DOR Code

of the retina. At first glance, it would seem improbable studies that have revealed the basic mechanisms by that full-fledged sodium action potentials would play a which odorant information in the periphery is reliably major role. Thus, the first stages of retinal processing transferred to the brain for higher order processing. are likely to remain analog rather than digital. However, The initi...

208 C*-algebras

Op-brhe140040 208..209

The introduction of TNF inhibitors more than a decade ago marked the beginning of an exciting era in the management of RA. Despite the development of biologics with alternative modes of action, TNF inhibitors remain today the most widely prescribed class of biologics for RA. However, tuberculosis (TB) is a major safety concern with TNF inhibitors. The risk of active TB is increased up to 56-fol...